In vitro susceptibility of clinical Clostridioides difficile isolates in Israel to metronidazole, vancomycin, fidaxomicin, ridinilazole and ibezapolstat,
RDZ and IBZ demonstrated potent in vitro activity against 313 C. difficile isolates belonging to different STs. These two antimicrobials may serve as effective agents for C. difficile infection.
Authors
- Avi Peretz (ORCID: https://orcid.org/0000-0002-9012-6015)
- Orna Schwartz
- Maya Azrad (ORCID: https://orcid.org/0000-0002-0110-1853)
Institutions
- Bar-Ilan University (IL)
- Wolfson Medical Center (IL)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-03-31
- DOI
- https://doi.org/10.1186/s12876-025-03800-7
- Citations
- 3
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 4.19